GJA1 and heart failure: The treated cardiomyocytes also showed elevated levels of BNP, a clinical marker of heart failure, a reduction in CX43 expression and downregulation of several calcium handling and ion channel related genes, changes commonly observed in the failing heart29 (Fig. 4B, C, Supplementary Fig. 4A, B).